Drugs / EU-Keytruda®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06280196 Comparator | Jul 2024 → Jul 2025 | non-small cell lung carcinoma | Bio-Thera Solutions | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EU-Keytruda | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06280196 ↗ |